STADA

Press Releases

Press Releases

Fidelity reports investment in STADA

Bad Vilbel – STADA Arzneimittel AG reports the following pursuant to section 25 (1) of the German Securities Trading Act (WpHG): Fidelity International Limited has reported pursuant to section 21 (1) of the German Securities Trading Act (WpHG) that Fidelity Funds – SICAV held more than 5% of the voting shares of STADA Arzneimittel AG on January 14, 2003. The above-mentioned fund now holds 1,090,555 registered STADA common shares, corresponding to 5.45% of its voting stock.

The remaining shares of STADA Arzneimittel AG continue to be held in free float.

Note:
Fidelity International Limited has now fallen below the 5% threshold again. Click here for further information on the current shareholder structure.

For more information, please contact:

STADA Arzneimittel AG
Corporate Communications
D-61118 Bad Vilbel
Tel.: +49 6101 603-113
Fax: +49 6101 603-506
e-mail: communications@stada.de

Career at STADA

Career at STADA

STADA's employees, with their extensive expertise, their experience and their strong commitment, play an important part in the longstanding success of the Group.

Learn more

Investor Relations

Investor Relations

Here you can find all the facts and background information about the STADA securities.

Learn more

Sustainability

Sustainability

For STADA "All the best" means taking responsibility.

Learn more

entdecken